Daniel J. Lovell

1987–2025 年に発表

別表記
Daniel J Lovell
107
論文数
19,995
被引用数
76
h 指数
104
i10 指数

被引用数

Daniel J. Lovell の年別被引用数1991 年: 被引用 3 件1992 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 4 件1996 年: 被引用 2 件1997 年: 被引用 6 件1998 年: 被引用 5 件1999 年: 被引用 12 件2000 年: 被引用 25 件2001 年: 被引用 18 件2002 年: 被引用 41 件2003 年: 被引用 66 件2004 年: 被引用 54 件2005 年: 被引用 95 件2006 年: 被引用 67 件2007 年: 被引用 84 件2008 年: 被引用 79 件2009 年: 被引用 108 件2010 年: 被引用 161 件2011 年: 被引用 165 件2012 年: 被引用 138 件2013 年: 被引用 127 件2014 年: 被引用 164 件2015 年: 被引用 152 件2016 年: 被引用 152 件2017 年: 被引用 127 件2018 年: 被引用 157 件2019 年: 被引用 593 件2020 年: 被引用 568 件2021 年: 被引用 622 件2022 年: 被引用 437 件2023 年: 被引用 287 件2024 年: 被引用 556 件2025 年: 被引用 115 件2026 年: 被引用 6 件1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,274 件、この内訳の 20.7%イギリス: 引用元論文 500 件、この内訳の 8.1%イタリア: 引用元論文 481 件、この内訳の 7.8%カナダ: 引用元論文 375 件、この内訳の 6.1%ドイツ: 引用元論文 370 件、この内訳の 6%オランダ: 引用元論文 261 件、この内訳の 4.2%中国: 引用元論文 245 件、この内訳の 4%フランス: 引用元論文 245 件、この内訳の 4%スペイン: 引用元論文 152 件、この内訳の 2.5%日本: 引用元論文 148 件、この内訳の 2.4%スイス: 引用元論文 136 件、この内訳の 2.2%トルコ: 引用元論文 126 件、この内訳の 2.1%
0%20.7%その他 29.9%

分野

  • Medicine73.7%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology6.4%
  • Health Professions1%
  • Social Sciences0.5%
  • Neuroscience0.3%
  • その他1%

トピック

  • Autoimmune and Inflammatory Disorders Research16.4%
  • Rheumatoid Arthritis Research and Therapies6.8%
  • Inflammasome and immune disorders6.6%
  • Adolescent and Pediatric Healthcare4.9%
  • Spondyloarthritis Studies and Treatments3%
  • Systemic Lupus Erythematosus Research2.9%
  • その他59.4%

共著者

全論文

検索で開く
  1. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Arthritis & Rheumatology 2015 被引用: 771

  2. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    著者: , , , , , , , , , , , , , , - The Journal of Rheumatology 2018 被引用: 546

  3. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Irina Lazariciu, Ming-Ann Hsu, Ricardo M Suehiro, Alberto Martini, Daniel J Lovell, R Cuttica, J Akikusa, J Chaitow, C Wouters, S Oliveira, CLS Neiva, M Santiago, CA Silva, MT Terreri, C Magalhaes, V De Souza, M Bandeira, G Chédeville, K Houghton, M Vazquez-Del Mercado, J Rizo Rodriguez, K Kobusinska, E Alexeeva, I Calvo Penades, AL Boteanu, O Kasapcopur, MH Poyrazoglu, M Erguven, S Ozen, E Al-Abadi, J Bohnsack, R Carrasco, J Dare, B Gottlieb, D Wahezi, L Jung, M Klein-Gitelman, Y Zhang, L Wagner-Weiner, S Tarvin, RK Vehe, P Chiraseveenuprapund, R Rivas-Chacon, W De La Pena, ACP Sagcal-Gironella, JE Weiss - The Lancet 2021 被引用: 187

  4. Juvenile idiopathic arthritis

    著者: , , , , , , - Nature Reviews Disease Primers 2022 被引用: 281

  5. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 873

  6. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 被引用: 481

  7. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Annals of the Rheumatic Diseases 2016 被引用: 397

  8. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 193

  9. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Flávio Sztajnbok, K. Lheritier, Kenneth Abrams, Dennis Kim, Alberto Martini, Daniel J. Lovell - New England Journal of Medicine 2012 被引用: 709

  10. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James Reston - Arthritis & Rheumatology 2022 被引用: 231

  11. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 被引用: 310

  12. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahya Aghighi, Maya-Feriel Aiche, Constantin Ailioaie, Nuray Aktay Ayaz, Safiya Al‐Abrawi, Е.I. Alexeeva, Jordi Antón, Adriana Apostol, O Arguedas, Tadej Avčin, Patrizia Barone, Lillemor Berntson, Alina Boteanu, Yaryna Boyko, Rubén Burgos‐Vargas, Inmaculada Calvo Penadés, Gaëlle Chédeville, Rolando Cimaz, Adele Civino, Rita Consolini, Tamás Constantin, Rubén Cuttica, Tomas Dallos, Neil A. Martin, Silvia Magni‐Manzoni, Carmen De Cunto, Pavla Doležalová, Maria Ekelund, Yasser El Miedany, Graciela Espada, Anne Estmann Christensen, Ivan Foeldvari, Romina Gallizzi, Gerd Ganser, V. Gerloni, Johannes‐Peter Haas, Liora Harel, Miroslav Harjaček, Soad Hashad, Troels Herlin, Cristina Herrera, Michaël Hofer, Dirk Holzinger, Gerd Horneff, Hans-Iko Huppertz, N Iagăru, Amparo Ibanez Estrella, Maka Ioseliani, Rik Joos, Sheila Knupp Feitosa de Oliveira, Sylvia Kamphuis, Özgür Kasapçopur, María Martha Katsicas, Raju Khubchandani, Anuela Kondi, Liisa Kröger, Francesco La Torre, Matilda Láday, Pekka Lahdenne, Maria Cristina Maggio, Maria Greca Magnolia, Clara Malagón, Merja Malin, Silvana Martino, José Melo‐Gomes, Pablo Mesa-del-Castillo, Andrea Militaru, Kirsten Minden, Angela Miniaci, Mohammad Hasan Moradinejad ほか 40 名 - The Lancet Child & Adolescent Health 2019 被引用: 214

  13. Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josef S Smolen - Annals of the Rheumatic Diseases 2018 被引用: 357

  14. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 被引用: 110

  15. Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

    著者: , , , , , , , , , , , , , - Diabetes Care 2015 被引用: 92

  16. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphaela Goldbach‐Mansky - Arthritis & Rheumatism 2002 被引用: 703

  17. Preliminary definition of improvement in juvenile arthritis

    著者: , , , , , - Arthritis & Rheumatism 1997 被引用: 1,052

  18. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

    著者: , , , , , , , , , - Arthritis & Rheumatology 2015 被引用: 129

  19. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA‐125a‐5p in Polarized Monocyte Phenotypes

    著者: , , , , , , - Arthritis & Rheumatology 2016 被引用: 92

  20. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 77

  21. New Medications Are Needed for Children With Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2020 被引用: 60

  22. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition

    著者: , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2019 被引用: 118

  23. Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 被引用: 627

  24. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

    著者: , , , , , , , , , , , , , , , - Arthritis Care & Research 2010 被引用: 272